Shanghai Daily: Business - shanghaidaily.com
FISHER & Paykel Healthcare Corp, the New Zealand-based maker of breathing masks to treat sleep disorders, rose to a three-month high in Wellington after the takeover of a rival stoked speculation about more mergers. The Auckland-based company jumped three percent to its highest since September 20, after Respironics Inc, the world's largest manufacturer of the breathing devices, was acquired by Royal Phillips Electronics NV for US$5.2 billion in cash, Bloomberg News reported. Fisher & Paykel has about seven percent of the market for products to treat obstructive sleep apnea, a condition thought to affect as many as 12 million Americans. It is among a handful of companies with US Food & Drug Administration approval to sell OSA devices, along with Respironics and ResMed Inc. "They definitely could be a takeover target because the OSA market is very attractive with its high growth," said Stephen Walker, who manages the equivalent of US$107 million at Walker Capital